hotspot -WSS

hotspot

author：focus 2025-09-28 00:49:31 - browse：44

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Generate Biomedicines machine learning biotech raises $273M

WSS

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Roche’s Alnylam deal shows drug firms interested in heart drugs

Senate panel puts off hardest PBM reforms for another day

Rise in cancer among younger people worries and puzzles doctors

Pig kidney works a record two months in donated body

Long Covid needs a new name — and a new frame

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Hollywood unions extend contract negotiations for actors

Food makers to regulators: Ultra

In age of alternative facts, a scholarly course on calling out crap

STAT Report: Patient voices and perspectives

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New Alzheimer's drugs heat up race for early detection blood tests

Novavax promises a turnaround & Lilly roils the obesity market

CDC Director Mandy Cohen on transparency, trust, and health

Wikipedia

Long Covid needs a new name — and a new frame

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Walmart eyes Medicare Advantage provider ChenMed

Food makers tried to stack nutrition panel with preferred experts

UHS says company favors patients whose insurance pays more

Roche’s Alnylam deal shows drug firms interested in heart drugs

entertainment

Wikipedia

leisure time

explore